PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Müller, T.D. ; Tschöp, M.H.

Gut-hormone triple agonists: Clinical safety and metabolic benefits.

Lancet 400, 1826-1828 (2022)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Letter to the Editor
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0140-6736
e-ISSN 0099-5355
Journal Lancet, The
Quellenangaben Volume: 400, Issue: 10366, Pages: 1826-1828 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Obesity (IDO)
POF-Topic(s) 30201 - Metabolic Health
90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502200-001
G-501900-221
DOI 10.1016/S0140-6736(22)02350-9
Scopus ID 85142432260
PubMed ID 36436519
Erfassungsdatum 2022-12-05
[➜Report correction]